News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
US Jury’s Neurontin Ruling To Cost Pfizer Inc. $142 Million
March 26, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Philadelphia Inquirer -- Pfizer Inc. was found by a jury yesterday to have committed racketeering fraud in the marketing of its epilepsy drug Neurontin and must pay $142.1 million in damages.
Twitter
LinkedIn
Facebook
Email
Print
Legal
MORE ON THIS TOPIC
Policy
Monarez Fired From Top CDC Spot Following Friction Over New COVID-19 Vaccine Policy
August 28, 2025
·
3 min read
·
Heather McKenzie
Regulatory
The US Is Losing Its Biopharma Edge, Writes Former FDA Commissioner
August 27, 2025
·
3 min read
·
Dan Samorodnitsky
COVID-19
CDC Names Vaccine Critic Retsef Levi as Head of COVID-19 Workgroup
August 26, 2025
·
2 min read
·
Tristan Manalac
Vaccines
Trump, Kennedy Could Ban COVID-19 Vaccine ‘Within Months’: Report
August 26, 2025
·
2 min read
·
Tristan Manalac
